Press "Enter" to skip to content

Pfizer to buy cancer drug developer Array for $10.64 billion

The offer of $48 per Array share represents a premium of about 62% to the stock’s close on Friday. Array’s shares surged 56% in light premarket trade.

Original source: https://health.economictimes.indiatimes.com/news/pharma/pfizer-to-buy-cancer-drug-developer-array-for-10-64-billion/69825966?utm_source=RSS&utm_medium=ETRSS

Also Read:   US health regulator finds Silvassa unit non-compliant with CGMP: Ipca Labs